cagrilintide and semaglutide In a phase 3a study of adults with early-stage type 2 diabetes inadequately controlled with diet exercise, once-weekly cagrilintide–semaglutide reduced HbA1c vs placebo and was associated with body weight reductions over 1 CagriSema 2.4 mg /
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 12 - Aug 17



























